/Investor DB

Matrix Capital Management — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Anumanaanumana.aiin𝕏Apr 2025

Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making.

AI & Machine LearningBiotechDigital HealthMedical DevicesCambridge, US

Murali Aravamudan(Executive Chairman of the Board; co-founder of nference)inMaulik Nanavaty(Chief Executive Officer)inHarris Fishman(Executive Officer)Alan Colowick(Director)Cheranjit Rihal(Director)David Goel(Director)

Co-investorsNTT Venture CapitalMatrix

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.